Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
32 current organizations shown on this profile
Board positions
22 supported by public sources, 0 supplied by the profile owner
Committee roles
1Roles supported by the sources cited on this profile
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

Alpha has not published a narrative summary because the current public source set is not sufficient.

Current roles

Appointments & responsibilities

Executive appointments

EXEC. CHAIR & PRINCIPAL OFF

Protagenic Therapeutics, Inc.\new (OTC: PTIX)

Current

Source effective: 2026-08-20 · Observed: 2026-09-05T08:43:03.086+00:00

confirmedView source

Board appointments

Director

Protagenic Therapeutics, Inc.\new (OTC: PTIX)

Current

Independence: Not stated

Source effective: 2026-08-20 · Observed: 2026-09-05T08:43:03.086+00:00

confirmedView source

Governance

Board appointments, committee responsibilities and disclosed relationships.

Connections

Explore the roles, education and affiliations published in this record.

AGENUS INC

Open AGENUS INC profile →

Director at AGENUS INC

1999-01-01 → End not stated

current · source reported

Observed: 2026-09-13

AGENUS INCAGENUS INCProtagenic Therape…Protagenic Therapeutics, Inc.\newProtagenic Therape…Protagenic Therapeutics, Inc.\newGaro H. Armen

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

  • AGENUS INC

    Director

    Verified public fact

  • Protagenic Therapeutics, Inc.\new

    EXEC. CHAIR & PRINCIPAL OFF

    Verified public fact

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec Form OwnershipPublic profile sourceSupports EXEC. CHAIR & PRINCIPAL OFF at Protagenic Therapeutics, Inc.\new (OTC: PTIX), Director at Protagenic Therapeutics, Inc.\new (OTC: PTIX), Executive title, Board membership.Open sourceSource 2 · Sec FilingAGEN DEF 14A executive officersSupports Executive company, Executive title.Open sourceSource 3 · Sec FilingAGEN DEF 14A director slateSupports AI and ML experience, Board role, Committee assignments, Executive company, Executive title, Cybersecurity experience, Technology background.Open sourceSource 4 · Sec FilingPTIX 10-K executive officersSupports AI and ML experience, Cybersecurity experience, Executive company, Executive title, Other Company Role, Technology background.Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:garo-h-armen
Record version
public-0

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

AI and ML experience · CorroboratedAI and ML experience: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Board membership · Source reportedServes on the board of AGENUS INC1 source
Verification
Source reported
Confidence
85%
Last reviewed
May 16, 2026
Board membership · Source reportedServes on the board of Protagenic Therapeutics, Inc.\new1 source
Verification
Source reported
Confidence
100%
Last reviewed
May 16, 2026
Board role · Source reportedBoard role: Chair1 source
Verification
Source reported
Confidence
92%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Committee assignments · Source reportedCommittee assignments: Executive1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Cybersecurity experience · CorroboratedCybersecurity experience: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive company · CorroboratedExecutive at Agenus Inc.Supported by 2 public records2 sources
Verification
Corroborated
Confidence
94%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Executive company · Source reportedExecutive at Protagenic Therapeutics, Inc.new1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive title · Source reportedExecutive title: Chairman and Chief Executive Officer1 source
Verification
Source reported
Confidence
85%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Executive title · Source reportedExecutive title: Chief Commercial Officer1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Executive title · Source reportedExecutive title: EXEC. CHAIR & PRINCIPAL OFF1 source
Verification
Source reported
Confidence
100%
Last reviewed
May 16, 2026
Executive title · Source reportedExecutive title: Executive Chairman of the Board of Directors1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Other Company Role · Source reportedGaro H. Armen is also linked to Agenus Inc. as Chairman and Chief Executive Officer.1 source
Verification
Source reported
Confidence
70%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Technology background · Under reviewTechnology background: not identified in the cited filing1 source
Verification
Under review
Confidence
72%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Technology background · Under reviewTechnology background reported in filings1 source
Verification
Under review
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

View all sources5 records
  1. https://www.sec.gov/Archives/edgar/data/1022899/000149315226039537/ownership.xml

    Sec Form Ownership · Tier not stated · Reviewed Sep 5, 2026

    Supports: EXEC. CHAIR & PRINCIPAL OFF at Protagenic Therapeutics, Inc.\new (OTC: PTIX) · Director at Protagenic Therapeutics, Inc.\new (OTC: PTIX) · Executive title · Board membership

  2. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

    Supports: Executive company · Executive title

  3. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

    Supports: AI and ML experience · Board role · Committee assignments · Executive company · Executive title · Cybersecurity experience · Technology background

  4. https://www.sec.gov/Archives/edgar/data/1098972/000095017025061030/agen-20250430.htm

    Sec Proxy · Tier not stated · Reviewed Apr 24, 2026

    Supports: Director at AGENUS INC (NASDAQ: AGEN) · Board membership

  5. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

    Supports: AI and ML experience · Cybersecurity experience · Executive company · Executive title · Other Company Role · Technology background